市場調査レポート概要
目次
Description
Table of Contents
Figures
List of Tables Table 1. Global Vaccine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030 Table 2. Major Companies of Varicella Vaccine Table 3. Major Companies of Influenza Vaccine Table 4. Major Companies of Polio Vaccine Table 5. Major Companies of Hepatitis A Vaccine Table 6. Major Companies of Rabies Vaccine Table 7. Major Companies of BCG Vaccine Table 8. Major Companies of Hepatitis B Table 9. Major Companies of Pertussis, Diphtheria, Tetanus Table 10. Major Companies of Pneumococcal Table 11. Major Companies of Others Table 12. Global Vaccine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030 Table 13. Global Vaccine Market Size by Region (US$ Million): 2023 VS 2030 Table 14. Global Vaccine Revenue by Region (2019-2024) & (US$ Million) Table 15. Global Vaccine Revenue Forecast by Region (2025-2030) & (US$ Million) Table 16. Vaccine Revenue by Company (2019-2024) & (US$ Million) Table 17. Vaccine Revenue Share by Company (2019-2024) Table 18. Ranking of Global Top Vaccine Players by Revenue (US$ Million) in 2023 Table 19. Global Vaccine Companies Market Concentration Ratio (CR5 and HHI) & (2019-2024) Table 20. Global Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaccine as of 2023) Table 21. Global Vaccine Companies Headquarters Table 22. Global Vaccine Companies Product & Service Table 23. Date of International Companies Enter into Vaccine Market Table 24. Global Vaccine Mergers & Acquisitions, Expansion Plans Table 25. AstraZeneca Company Information Table 26. AstraZeneca Description and Business Overview Table 27. AstraZeneca Vaccine Product Table 28. AstraZeneca Vaccine Revenue (US$ Million) and Gross Margin (2019-2024) Table 29. AstraZeneca Revenue Proportion of Vaccine by Product in 2023 Table 30. AstraZeneca Revenue Proportion of Vaccine by Application in 2023 Table 31. AstraZeneca Revenue Proportion of Vaccine by Geographic Area in 2023 Table 32. AstraZeneca Recent Development Table 33. BioNTech Company Information Table 34. BioNTech Description and Business Overview Table 35. BioNTech Vaccine Product Table 36. BioNTech Vaccine Revenue (US$ Million) and Gross Margin (2019-2024) Table 37. BioNTech Revenue Proportion of Vaccine by Product in 2023 Table 38. BioNTech Revenue Proportion of Vaccine by Application in 2023 Table 39. BioNTech Revenue Proportion of Vaccine by Geographic Area in 2023 Table 40. BioNTech Recent Development Table 41. Boehringer-Ingelheim Company Information Table 42. Boehringer-Ingelheim Description and Business Overview Table 43. Boehringer-Ingelheim Vaccine Product Table 44. Boehringer-Ingelheim Vaccine Revenue (US$ Million) and Gross Margin (2019-2024) Table 45. Boehringer-Ingelheim Revenue Proportion of Vaccine by Product in 2023 Table 46. Boehringer-Ingelheim Revenue Proportion of Vaccine by Application in 2023 Table 47. Boehringer-Ingelheim Revenue Proportion of Vaccine by Geographic Area in 2023 Table 48. Boehringer-Ingelheim Recent Development Table 49. CCBIO Company Information Table 50. CCBIO Description and Business Overview Table 51. CCBIO Vaccine Product Table 52. CCBIO Vaccine Revenue (US$ Million) and Gross Margin (2019-2024) Table 53. CCBIO Revenue Proportion of Vaccine by Product in 2023 Table 54. CCBIO Revenue Proportion of Vaccine by Application in 2023 Table 55. CCBIO Revenue Proportion of Vaccine by Geographic Area in 2023 Table 56. CCBIO Recent Development Table 57. CSL Company Information Table 58. CSL Description and Business Overview Table 59. CSL Vaccine Product Table 60. CSL Vaccine Revenue (US$ Million) and Gross Margin (2019-2024) Table 61. CSL Revenue Proportion of Vaccine by Product in 2023 Table 62. CSL Revenue Proportion of Vaccine by Application in 2023 Table 63. CSL Revenue Proportion of Vaccine by Geographic Area in 2023 Table 64. CSL Recent Development Table 65. CureVac Company Information Table 66. CureVac Description and Business Overview Table 67. CureVac Vaccine Product Table 68. CureVac Vaccine Revenue (US$ Million) and Gross Margin (2019-2024) Table 69. CureVac Revenue Proportion of Vaccine by Product in 2023 Table 70. CureVac Revenue Proportion of Vaccine by Application in 2023 Table 71. CureVac Revenue Proportion of Vaccine by Geographic Area in 2023 Table 72. CureVac Recent Development Table 73. Elanco Company Information Table 74. Elanco Description and Business Overview Table 75. Elanco Vaccine Product Table 76. Elanco Vaccine Revenue (US$ Million) and Gross Margin (2019-2024) Table 77. Elanco Revenue Proportion of Vaccine by Product in 2023 Table 78. Elanco Revenue Proportion of Vaccine by Application in 2023 Table 79. Elanco Revenue Proportion of Vaccine by Geographic Area in 2023 Table 80. Elanco Recent Development Table 81. GSK Company Information Table 82. GSK Description and Business Overview Table 83. GSK Vaccine Product Table 84. GSK Vaccine Revenue (US$ Million) and Gross Margin (2019-2024) Table 85. GSK Revenue Proportion of Vaccine by Product in 2023 Table 86. GSK Revenue Proportion of Vaccine by Application in 2023 Table 87. GSK Revenue Proportion of Vaccine by Geographic Area in 2023 Table 88. GSK Recent Development Table 89. Hulan Bio Company Information Table 90. Hulan Bio Description and Business Overview Table 91. Hulan Bio Vaccine Product Table 92. Hulan Bio Vaccine Revenue (US$ Million) and Gross Margin (2019-2024) Table 93. Hulan Bio Revenue Proportion of Vaccine by Product in 2023 Table 94. Hulan Bio Revenue Proportion of Vaccine by Application in 2023 Table 95. Hulan Bio Revenue Proportion of Vaccine by Geographic Area in 2023 Table 96. Hulan Bio Recent Development Table 97. Indian Immunologicals Company Information Table 98. Indian Immunologicals Description and Business Overview Table 99. Indian Immunologicals Vaccine Product Table 100. Indian Immunologicals Vaccine Revenue (US$ Million) and Gross Margin (2019-2024) Table 101. Indian Immunologicals Revenue Proportion of Vaccine by Product in 2023 Table 102. Indian Immunologicals Revenue Proportion of Vaccine by Application in 2023 Table 103. Indian Immunologicals Revenue Proportion of Vaccine by Geographic Area in 2023 Table 104. Indian Immunologicals Recent Development Table 105. Merck Company Information Table 106. Merck Description and Business Overview Table 107. Merck Vaccine Product Table 108. Merck Vaccine Revenue (US$ Million) and Gross Margin (2019-2024) Table 109. Merck Revenue Proportion of Vaccine by Product in 2023 Table 110. Merck Revenue Proportion of Vaccine by Application in 2023 Table 111. Merck Revenue Proportion of Vaccine by Geographic Area in 2023 Table 112. Merck Recent Development Table 113. Minhai Biotechnology Company Information Table 114. Minhai Biotechnology Description and Business Overview Table 115. Minhai Biotechnology Vaccine Product Table 116. Minhai Biotechnology Vaccine Revenue (US$ Million) and Gross Margin (2019-2024) Table 117. Minhai Biotechnology Revenue Proportion of Vaccine by Product in 2023 Table 118. Minhai Biotechnology Revenue Proportion of Vaccine by Application in 2023 Table 119. Minhai Biotechnology Revenue Proportion of Vaccine by Geographic Area in 2023 Table 120. Minhai Biotechnology Recent Development Table 121. Mitsubishi Tanabe Pharma Company Information Table 122. Mitsubishi Tanabe Pharma Description and Business Overview Table 123. Mitsubishi Tanabe Pharma Vaccine Product Table 124. Mitsubishi Tanabe Pharma Vaccine Revenue (US$ Million) and Gross Margin (2019-2024) Table 125. Mitsubishi Tanabe Pharma Revenue Proportion of Vaccine by Product in 2023 Table 126. Mitsubishi Tanabe Pharma Revenue Proportion of Vaccine by Application in 2023 Table 127. Mitsubishi Tanabe Pharma Revenue Proportion of Vaccine by Geographic Area in 2023 Table 128. Mitsubishi Tanabe Pharma Recent Development Table 129. Moderna Therapeutics Company Information Table 130. Moderna Therapeutics Description and Business Overview Table 131. Moderna Therapeutics Vaccine Product Table 132. Moderna Therapeutics Vaccine Revenue (US$ Million) and Gross Margin (2019-2024) Table 133. Moderna Therapeutics Revenue Proportion of Vaccine by Product in 2023 Table 134. Moderna Therapeutics Revenue Proportion of Vaccine by Application in 2023 Table 135. Moderna Therapeutics Revenue Proportion of Vaccine by Geographic Area in 2023 Table 136. Moderna Therapeutics Recent Development Table 137. Mylan Company Information Table 138. Mylan Description and Business Overview Table 139. Mylan Vaccine Product Table 140. Mylan Vaccine Revenue (US$ Million) and Gross Margin (2019-2024) Table 141. Mylan Revenue Proportion of Vaccine by Product in 2023 Table 142. Mylan Revenue Proportion of Vaccine by Application in 2023 Table 143. Mylan Revenue Proportion of Vaccine by Geographic Area in 2023 Table 144. Mylan Recent Development Table 145. Plumbline Life Sciences Company Information Table 146. Plumbline Life Sciences Description and Business Overview Table 147. Plumbline Life Sciences Vaccine Product Table 148. Plumbline Life Sciences Vaccine Revenue (US$ Million) and Gross Margin (2019-2024) Table 149. Plumbline Life Sciences Revenue Proportion of Vaccine by Product in 2023 Table 150. Plumbline Life Sciences Revenue Proportion of Vaccine by Application in 2023 Table 151. Plumbline Life Sciences Revenue Proportion of Vaccine by Geographic Area in 2023 Table 152. Plumbline Life Sciences Recent Development Table 153. Sanofi Company Information Table 154. Sanofi Description and Business Overview Table 155. Sanofi Vaccine Product Table 156. Sanofi Vaccine Revenue (US$ Million) and Gross Margin (2019-2024) Table 157. Sanofi Revenue Proportion of Vaccine by Product in 2023 Table 158. Sanofi Revenue Proportion of Vaccine by Application in 2023 Table 159. Sanofi Revenue Proportion of Vaccine by Geographic Area in 2023 Table 160. Sanofi Recent Development Table 161. Translate Bio Company Information Table 162. Translate Bio Description and Business Overview Table 163. Translate Bio Vaccine Product Table 164. Translate Bio Vaccine Revenue (US$ Million) and Gross Margin (2019-2024) Table 165. Translate Bio Revenue Proportion of Vaccine by Product in 2023 Table 166. Translate Bio Revenue Proportion of Vaccine by Application in 2023 Table 167. Translate Bio Revenue Proportion of Vaccine by Geographic Area in 2023 Table 168. Translate Bio Recent Development Table 169. Walvax Biotechnology Company Information Table 170. Walvax Biotechnology Description and Business Overview Table 171. Walvax Biotechnology Vaccine Product Table 172. Walvax Biotechnology Vaccine Revenue (US$ Million) and Gross Margin (2019-2024) Table 173. Walvax Biotechnology Revenue Proportion of Vaccine by Product in 2023 Table 174. Walvax Biotechnology Revenue Proportion of Vaccine by Application in 2023 Table 175. Walvax Biotechnology Revenue Proportion of Vaccine by Geographic Area in 2023 Table 176. Walvax Biotechnology Recent Development Table 177. Wuhan Institute of Biological Products Company Information Table 178. Wuhan Institute of Biological Products Description and Business Overview Table 179. Wuhan Institute of Biological Products Vaccine Product Table 180. Wuhan Institute of Biological Products Vaccine Revenue (US$ Million) and Gross Margin (2019-2024) Table 181. Wuhan Institute of Biological Products Revenue Proportion of Vaccine by Product in 2023 Table 182. Wuhan Institute of Biological Products Revenue Proportion of Vaccine by Application in 2023 Table 183. Wuhan Institute of Biological Products Revenue Proportion of Vaccine by Geographic Area in 2023 Table 184. Wuhan Institute of Biological Products Recent Development Table 185. Zoties Company Information Table 186. Zoties Description and Business Overview Table 187. Zoties Vaccine Product Table 188. Zoties Vaccine Revenue (US$ Million) and Gross Margin (2019-2024) Table 189. Zoties Revenue Proportion of Vaccine by Product in 2023 Table 190. Zoties Revenue Proportion of Vaccine by Application in 2023 Table 191. Zoties Revenue Proportion of Vaccine by Geographic Area in 2023 Table 192. Zoties Recent Development Table 193. Global Vaccine Revenue by Type (2019-2024) & (US$ Million) Table 194. Global Vaccine Revenue Forecast by Type (2025-2030) & (US$ Million) Table 195. Global Vaccine Revenue by Application (2019-2024) & (US$ Million) Table 196. Global Vaccine Revenue Forecast by Application (2025-2030) & (US$ Million) Table 197. North America Vaccine Revenue by Country (2019-2024) & (US$ Million) Table 198. North America Vaccine Revenue by Country (2025-2030) & (US$ Million) Table 199. North America Vaccine Revenue by Type (2019-2024) & (US$ Million) Table 200. North America Vaccine Revenue by Application (2019-2024) & (US$ Million) Table 201. Asia-Pacific Vaccine Revenue by Region (2019-2030) & (US$ Million) Table 202. Asia-Pacific Vaccine Revenue by Region (2025-2030) & (US$ Million) Table 203. Asia-Pacific Vaccine Revenue by Type (2019-2024) & (US$ Million) Table 204. Asia-Pacific Vaccine Revenue by Application (2019-2024) & (US$ Million) Table 205. Europe Vaccine Revenue by Country (2019-2024) & (US$ Million) Table 206. Europe Vaccine Revenue by Country (2025-2030) & (US$ Million) Table 207. Europe Vaccine Revenue by Type (2019-2024) & (US$ Million) Table 208. Europe Vaccine Revenue by Application (2019-2024) & (US$ Million) Table 209. Latin America Vaccine Revenue by Country (2019-2024) & (US$ Million) Table 210. Latin America Vaccine Revenue by Country (2025-2030) & (US$ Million) Table 211. Latin America Vaccine Revenue by Type (2019-2024) & (US$ Million) Table 212. Latin America Vaccine Revenue by Application (2019-2024) & (US$ Million) Table 213. Middle East and Africa Vaccine Revenue by Country (2019-2024) & (US$ Million) Table 214. Middle East and Africa Vaccine Revenue by Country (2025-2030) & (US$ Million) Table 215. Middle East and Africa Vaccine Revenue by Type (2019-2024) & (US$ Million) Table 216. Middle East and Africa Vaccine Revenue by Application (2019-2024) & (US$ Million) Table 217. Vaccine Key Raw Materials, Industry Status and Trend Table 218. Vaccine Key Raw Materials and Upstream Suppliers Table 219. Vaccine Clients Status and Trend Table 220. Vaccine Typical Clients Table 221. Vaccine Distributors Table 222. Vaccine Market Trends Table 223. Vaccine Market Drivers Table 224. Vaccine Market Challenges Table 225. Vaccine Market Restraints Table 226. Research Programs/Design for This Report Table 227. Key Data Information from Secondary Sources Table 228. Key Data Information from Primary Sources List of Figures Figure 1. Vaccine Product Picture Figure 2. Global Vaccine Revenue Market Share by Type in 2023 & 2030 Figure 3. Varicella Vaccine Product Picture Figure 4. Influenza Vaccine Product Picture Figure 5. Polio Vaccine Product Picture Figure 6. Hepatitis A Vaccine Product Picture Figure 7. Rabies Vaccine Product Picture Figure 8. BCG Vaccine Product Picture Figure 9. Hepatitis B Product Picture Figure 10. Pertussis, Diphtheria, Tetanus Product Picture Figure 11. Pneumococcal Product Picture Figure 12. Global Vaccine Revenue Market Share by Application in 2023 & 2030 Figure 13. For Adult Figure 14. For Child Figure 15. Vaccine Report Years Considered Figure 16. Global Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030 Figure 17. Global Vaccine Market Size 2019-2030 (US$ Million) Figure 18. Global Vaccine Market Size Market Share by Region: 2023 Versus 2030 Figure 19. Global Vaccine Revenue Market Share by Region (2019-2030) Figure 20. Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023 Figure 21. Global Vaccine Revenue Market Share Forecast by Type (2019-2030) Figure 22. Global Vaccine Revenue Market Share Forecast by Application (2019-2030) Figure 23. North America Vaccine Revenue 2019-2030 (US$ Million) Figure 24. North America Vaccine Revenue Market Share by Type (2019-2024) Figure 25. North America Vaccine Revenue Market Share by Application (2019-2024) Figure 26. Asia-Pacific Vaccine Revenue 2019-2030 (US$ Million) Figure 27. Asia-Pacific Vaccine Revenue Market Share by Region (2019-2030) Figure 28. Asia-Pacific Vaccine Revenue Market Share by Type (2019-2024) Figure 29. Asia-Pacific Vaccine Revenue Market Share by Application (2019-2024) Figure 30. Europe Vaccine Revenue Growth Rate 2019-2030 (US$ Million) Figure 31. Europe Vaccine Revenue Market Share by Country (2019-2030) Figure 32. Europe Vaccine Revenue Market Share by Type (2019-2024) Figure 33. Europe Vaccine Revenue Market Share by Application (2019-2024) Figure 34. Latin America Vaccine Revenue Growth Rate 2019-2030 (US$ Million) Figure 35. Latin America Vaccine Revenue Market Share by Country (2019-2024) Figure 36. Latin America Vaccine Revenue Market Share by Type (2019-2024) Figure 37. Latin America Vaccine Revenue Market Share by Application (2019-2024) Figure 38. Middle East and Africa Vaccine Revenue Growth Rate 2019-2030 (US$ Million) Figure 39. Middle East and Africa Vaccine Revenue Market Share by Country (2019-2030) Figure 40. Middle East and Africa Vaccine Revenue Market Share by Type (2019-2024) Figure 41. Middle East and Africa Vaccine Revenue Market Share by Application (2019-2024) Figure 42. Vaccine Supply Chain (Upstream and Downstream Market) Figure 43. Global Production Market Share of Vaccine Raw Materials by Region in 2023 Figure 44. Vaccine Distribution Channels Figure 45. Global Vaccine Percentage 2019-2030: Indirect Sales VS Direct Sales Figure 46. Global Vaccine Percentage 2019-2030: Online Sales VS Offline Sales Figure 47. Bottom-up and Top-down Approaches for This Report Figure 48. Data Triangulation Figure 49. Key Executives Interviewed Figure 50. Global Vaccine Percentage 2019-2030: Online Sales VS Offline Sales Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed
